CELVUS, created in 2006 (Switzerland), from 2951 sister brands and 17477 competing brands. CELVUS is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. CELVUS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(CELVUS)
over 5 years*
CHF 95.61